Stability of sodium valproate tablets repackaged into dose administration aids

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 7, 2010, Pages 838-843

  Llewelyn, Victoria K ^a   Mangan, Martina F ^a   Glass, Beverley D ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

dose administration aids; physicochemical stability; repackaging; sodium valproate

Indexed keywords

VALPROIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG PACKAGING; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIDITY; TEMPERATURE MEASUREMENT;

EID: 77953983820     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.07.0004     Document Type: Article

References (23)

1. School of Pharmacy and Medical Sciences, University of South Australia. Dose administration aids. Quality Use of Medicines Database online 1997 http://qummap.net.au/files/reports/12112699466799.pdf (accessed 12 August 2008).
2. Glass BD et al. Compliance aids and medicine stability: new evidence of quality assurance. Curr Drug Saf 2009 4 : 74 78.
3. Church C, Smith J. How stable are medicines moved from original packs into compliance aids? Pharm J 2006 276 : 75 81.
4. Chan K et al. Pilot study of the short-term physico-chemical stability of atenolol tablets stored in a multi-compartment compliance aid. Eur J Hosp Pharm Sci 2007 13 : 60 66.
5. Haywood A et al. Stability implications of repackaging paracetamol tablets into dose administration aids. J Pharm Prac Res 2006 36 : 25 28.
6. Bowen L et al. Stability of frusemide tablets repackaged in dose administration aids. J Pharm Prac Res 2007 37 : 178 181.
7. Glass BD et al. Prochlorperazine tablets repackaged into dose administration aids: can the patient be assured of quality? J Clin Pharm Ther 2009 34 : 161 169.
8. Pharmaceutical Society of Australia. Guidelines and standards for pharmacists - Dose administration aids service. Pharmaceutical Society of Australia [online 2007 http://www.psa.org.au/site.php?id=2065 (accessed 13 May 2008).
9. USP32/NF27 681. Repackaging into Single-unit Containers and Unit-dose Containers for Nonsterile Solid and Liquid Dosage Forms.
10. Royal Pharmaceutical Society of Great Britain. Medicines, Ethics, and Practice: a Guide for Pharmacists, Volume 27.
11. Henry TR. The history of valproate in clinical neuroscience. Psychopharmacol Bull 2003 37 (Suppl. 2 5 16.
12. Chang ZL. Sodium valproate and valproic acid. In : Florey K, ed. Analytical Profiles of Drug Substances. 8th edn.
13. The United States Pharmacopeial Convention. United States Pharmacopoeia 25th edn/National Formulary 20th edn.
14. ICH Q1F. Stability data package for registration applications in climatic zones III and IV: Note for guidance on stability datapackage for registration in climatic zones III and IV. Therapeutic Goods Administration [online 2003 http://www.tga.gov.au/docs/pdf/euguide/ich/042102.pdf (accessed 17 March 2008).
15. Therapeutic Goods Administration. EU guideline - As adopted in Australia by the TGA - with amendment: Validation of analytical procedures: Methodology (pp. 107 110 of Eudralex 1998, Volume 3A-3AQ13A). Therapeutic Goods Administration [online 2002 http://www.tga.gov.au/docs/pdf/euguide/vol3a/ 3aq13atga.pdf (accessed 17 March 2008).
16. British Pharmacopoeia. CD-ROM.
17. Davies I, Koves E. Analysis of basic drugs in postmortem blood by HPLC with diode array detection: Varian Application Note #12 online] n.d; http://www.varianinc.com/media/sci/apps/lc12.pdf (accessed 11 July 2008).
18. Sanofi-Synthelabo Australia Pty Ltd. Epilim® Product Information online 2007 http://www.sanofi-aventis.com.au/products/aus-pi-epilim.pdf (accessed 04 January 2008).
19. Klotz U, Antonin KH. Pharmacokinetics and bioavailability of sodium valproate. Clin Pharmacol Ther 1977 21 : 736 743.
20. Crawford P et al. Generic prescribing for epilepsy. Is it safe? Seizure 1996 5 : 1 5.
21. Crawford P et al. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues. Seizure 2006 15 : 165 176.
22. Bell WL et al. Reduced bioavailability of moisture-exposed carbamazepine resulting in status epilepticus. Epilepsia 1993 34 : 1102 1104.
23. Cloyd J et al. Reduced seizure control due to spoiled phenytoin capsules. Ann Neurol 1980 7 : 191 193.